Late diagnosis of Kawasaki disease is associated with haptoglobin phenotype

European Journal of Clinical Investigation

Volumn 30, Issue 5, 2000, Pages 379-382

  Lee, W C ^b   Hwang, K P ^b   King, Y T ^b   Chen, H C ^b   Chiou, S S ^b   Yang, R C ^b   Huang, Teh Yang ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b NONE

Author keywords

Coronary artery abnormality; Haptoglobin; Kawasaki disease; Phenotype

Indexed keywords

ACETYLSALICYLIC ACID; HAPTOGLOBIN; IMMUNOGLOBULIN; PROTEIN;

ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CORONARY ARTERY DISEASE; FEMALE; FEVER; HUMAN; IMMUNOBLOTTING; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NEPHELOMETRY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ACUTE DISEASE; CHILD; CHILD, PRESCHOOL; CORONARY VESSEL ANOMALIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; FEVER; HAPTOGLOBINS; HUMANS; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PHENOTYPE;

EID: 0034061616     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2000.00646.x     Document Type: Article

References (26)

1. 1 Dajani AS, Taubert KA, Gerber MA et al. Diagnosis and therapy of Kawasaki disease in children. Circulation 1993;87:1776-80.
2. 2 Shulman ST, De Inocencio J, Hirsch R. Kawasaki disease. Pediatr Rheumatol 1995;42:1205-22.
3. 3 Schaller JG. Vasculitis syndromes. In: Behrman RE, Kliegman RM, Arvin AM, and Nelson WE, editors. Nelson Textbook of Paediatrics. 15th ed. Philadephia: WB Saunders; 1996.p.676-82.
4. 4 Fujiwara T, Fujiwara H, Ueda T, Nishioka K, Hamashima Y. Comparison of macroscopic, postmortem, angiographic and two-dimensional echocardiographic findings of coronary aneurysms in children with Kawasaki disease. Am J Cardiol 1986;57:761-4.
5. 5 Loubser MD, Hoh MC, Sreeram N. Sudden death in incomplete Kawasaki disease. Arch Dis Child 1989;64:637-8.
6. 6 Furusho K, Kamiya T, Nakano H et al. Intravenous gammaglobulin for Kawasaki disease. Acta Paediatr Jpn 1991;33:799-804.
7. 7 Newberger JW, Takahashi M, Beiser AS et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 1991;315:341-7.
8. 8 Barron KS. Kawasaki disease in children. Curr Opin Rheumatol 1998;10:29-37.
9. 9 Lin CY, Lin CC, Hwang B, Chiang BN. Cytokines predict coronary aneurysm formation in Kawasaki disease patients. Eur J Pediatr 1993;152:309-12.
10. 10 Hwang KP, Wu JR, Huang LY, Liou CC, Huang TY. Clinical manifestations and effects of IVGG in patients with Kawasaki disease. Kaohsiung J Med Sci 1996;12:159-66.
11. 11 Blackwell RQ, Lin TY, Shiao DDF. Distribution of haptoglobins among Chinese in Taiwan. Nature 1962;193:284-5.
12. 12 Lianh CC, Qi ZB, Ying QL, Wang LF. Types and subtypes of haptoglobin in the Chinese population. Hum Genet 1983;63:175-7.
13. 13 Langlois MR, Delanghe JR. Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 1996;42:1589-600.
14. 14 Bernard DR, Langlois MR, Delanghe JR, De Buyzere ML. Evolution of haptoglobin concentration in serum during the early phase of acute myocardial infarction. Eur J Clin Chem Clin Biochem 1997;35:85-8.
15. 15 Delanghe J, Cambier B, Langlois M, De Buyzere M, Neels H, De Bacquer D et al. Haptoglobin polymorphism, a genetic risk factor in coronary artery bypass surgery. Atherosclerosis 1997;132:215-9.
16. 16 Morens DM, Anderson LJ, Hurwitz ES. National surveillance of Kawasaki disease. Paediatrics 1980;65:21-5.
17. 17 Hicks RV, Melish ME. Kawasaki syndrome. Pediatr Clin North Am 1986;33:1151-75.
18. 18 Takahashi M, Mason W, Lewis AB. Regression of coronary aneurysms in patients with Kawasaki syndrome. Circulation 1987;75:387-94.
19. 19 Lee WC, Lin KY, Chiu YT et al. Substantial decrease of HSP90 in ventricular tissue of two sudden death pigs with hypertrophic cardiomyopathy. FASEB J 1996;10:1198-204.
20. 20 SAS Institute. SAS User's Guide: Statistics Release 6.03. Cary, NC, USA: SAS Institute Inc; 1989.
21. 21 Park AH, Batchra N, Rowley A, Hotaling A. Patterns of Kawasaki syndrome presentation. Int J Pediatr Otorhinolaryngol 1997;40:41-50.
22. 22 Curtis N. Kawasaki disease: early recognition is vital to prevent cardiac complications. Br Med J 1997;315:322-3.
23. 23 Fujiwara H, Hamashima Y. Pathology of the heart in Kawasaki disease. Paediatrics 1978;61:100-7.
24. 24 Boven K, DeGraeff-Meeder ER, Spliet W, Kuis W. Atypical Kawasaki disease: an often missed diagnosis. Eur J Pediatr 1992;151:577-80.
25. 25 Powell JT, Bashir A, Dawson S, Vine N, Henney AM, Humphries SE et al. Genetic variation on chromosome 16 is associated with abdominal aortic aneurysm. Clin Sci 1990;78:13-6.
26. 26 Witt MT, Minich LL, Bohnsack JF, Young PC. Kawasaki disease: more patients are being diagnosed who do not meet American Heart Association criteria. Paediatrics 1999;104: e10.